DRIVE: A call for tenders

Measuring brand-specific influenza vaccine effectiveness in EU/EEA: A call for tenders

The IMI project DRIVE (Development of Robust and Innovative Vaccine Effectiveness) has issued a call for tenders to evaluate influenza vaccine effectiveness (IVE) by vaccine type and brand. Its purpose is to support the sharing of existing IVE data and to establish new IVE studies, including novel and innovative approaches. The call is open to any European organization, institution or network and closes on 10 June 2018; both existing and new IVE study sites may apply.

For more information, please contact info@drive-eu.org 

or visit: http://www.drive-eu.org/index.php/2018/05/02/call-for-tenders-2018-2019-influenza-season/


ECCMID 2018 - DRIVE is searching for new collaborators

DRIVE is searching for new collaborators for the next influenza season, to develop robust tools to measure influenza  vaccine effectiveness.

The DRIVE project for brand-specific influenza vaccine effectiveness studies will be presented at the ECCMID conference in Madrid, on 21-24 April 2018.

Find out more about DRIVE (Development of Robust and Innovative Vaccine Effectiveness)


Overcoming barriers in HPV vaccination and screening programs

Read the article >

Vorsters A, Arbyn M, Baay M, Bosch X, de Sanjosé S, Hanley S, Karafillakis E, Lopalco PL, Pollock KG, Yarwood J, Van Damme P. December 2017. Papillomavirus Research.